Patents-Review.com
🔗 Permalink
Assignee profile:

ZYMEWORKS BC INC.

City:

Vancouver

Country:

Canada

Published Applications:

15

Last publication date:

2024-12-26

Patent Grants:

15

Last grant date:

2025-10-07

Top Inventors for applications by ZYMEWORKS BC INC.

These are the the leading inventors for applications assigned to ZYMEWORKS BC INC.:

Recent patent applications by ZYMEWORKS BC INC.

ZYMEWORKS BC INC. based in Vancouver, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-12-26 ✅ Patent 12,433,952 granted on 2025-10-07
US20240424125A1
Human necessities

ANTIBODY-DRUG CONJUGATES TARGETING FOLATE RECEPTOR ALPHA AND METHODS OF USE

 #2 | 2024-10-03 ✅ Patent 12,304,954 granted on 2025-05-20
US20240327516A1
Chemistry; metallurgy

Multivalent and bispecific antibody constructs and methods of use thereof

 #3 | 2023-12-07 ✅ Patent 12,303,544 granted on 2025-05-20
US20230390354A1
Human necessities

Cytotoxic and anti-mitotic compounds, and methods of using the same

 #4 | 2023-04-20 ✅ Patent 12,215,166 granted on 2025-02-04
US20230118302A1
Chemistry; metallurgy

Bispecific antigen binding constructs targeting HER2

 #5 | 2022-08-11 ✅ Patent 12,286,489 granted on 2025-04-29
US20220251242A1
Chemistry; metallurgy

Modified antigen binding polypeptide constructs and uses thereof

 #6 | 2022-07-21 ✅ Patent 12,304,945 granted on 2025-05-20
US20220227840A1
Chemistry; metallurgy

Engineered immunoglobulin heavy chain-light chain pairs and uses thereof

 #7 | 2022-05-05 ✅ Patent 12,435,157 granted on 2025-10-07
US20220133903A1
Human necessities

METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 FOR THE TREATMENT OF BILIARY TRACT CANCERS

 #8 | 2021-12-30 ✅ Patent 11,965,036 granted on 2024-04-23
US20210403598A1
Chemistry; metallurgy

Bispecific antigen-binding constructs targeting HER2

 #9 | 2021-12-23 ✅ Patent 12,227,591 granted on 2025-02-18
US20210395388A1
Chemistry; metallurgy

Antigen-binding constructs targeting HER2

 #10 | 2021-11-18 ✅ Patent 12,540,198 granted on 2026-02-03
US20210355239A1
Chemistry; metallurgy

Antigen-Binding Polypeptide Constructs Comprising Kappa and Lambda Light Chains and Uses Thereof

 #11 | 2021-11-11 ✅ Patent 12,357,701 granted on 2025-07-15
US20210346508A1
Human necessities

ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

 #12 | 2021-10-07 ✅ Patent 12,060,436 granted on 2024-08-13
US20210309760A1
Chemistry; metallurgy

Engineered immunoglobulin heavy chain-light chain pairs and uses thereof

 #13 | 2021-06-24 ✅ Patent 12,157,775 granted on 2024-12-03
US20210189001A1
Chemistry; metallurgy

Methods of using bispecific antigen-binding constructs targeting HER2

 #14 | 2021-06-10 ✅ Patent 12,076,400 granted on 2024-09-03
US20210170023A1
Human necessities

Methods of using a bispecific antigen-binding construct targeting HER2 in combination with CDK4/6 inhibitors for the treatment of breast cancer

 #15 | 2020-10-01 ✅ Patent 11,965,019 granted on 2024-04-23
US20200308270A1
Chemistry; metallurgy

Stabilized chimeric Fabs

Also check out ZYMEWORKS BC INC.'s (Vancouver, Canada) applicant profile with 43 patent applications submitted.

AssigneeID:

344558 ⎘